MedPath

A self regulatory weight reduction intervention in diabetes type II patients.

Completed
Registration Number
NL-OMON25032
Lead Sponsor
-
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
270
Inclusion Criteria

Diabetes type II according to WHO classification (1999): fasting blood glucose levels > 126 mg/dl (7mmol/l) or levels > 200 mg/dl (11.1 mmol/l) two hours after an oral glucose tolerance test, treated by an internist from the Máxima Medical Centre, BMI 27-45, between 21 and 70 years old, Caucasian patients who are able to understand, read and write in Dutch.

Exclusion Criteria

Patients with any severe co morbidity (except for cardiovascular diseases) will be excluded. Patients who are currently under treatment for a psychological or psychiatric disorder will also be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. The main (biomedical) outcome measure in this intervention is GlyHb;<br><br /><br>2. The main behavioural outcome measure in this intervention is weight in kilograms. This will be measured at baseline and throughout the intervention in both the intervention and the standard care groups;<br><br />3. Dietary and exercise behaviour will be assessed throughout the intervention by means of a short diary procedure. Patients will be asked to shortly write down their nutrition and exercise behaviour from the past week; <br><br />4. Psychological outcome measures refer to various psychological factors that may facilitate or inhibit progress toward the weight reduction goals (see also secondary outcome).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath